Home/Filings/4/0000899243-21-032177

4//SEC Filing

Versant Affiliates Fund V, L.P. 4

Accession 0000899243-21-032177

CIK 0001808158other

View on SEC.gov Company Profile

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:44 PM ET

Size

37.2 KB

Accession

0000899243-21-032177

Insider Transaction Report

Form 4

Period: 2021-08-05

Repare Therapeutics Inc.RPTX

Versant Affiliates Fund V, L.P.

10% Owner

Transactions

Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
144,879

Versant Venture Capital V (Canada), LP

10% Owner

Transactions

Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
144,879
Common Shares
(indirect: See Footnote)
2,594,451

Versant Venture Capital V, L.P.

10% Owner

Transactions

Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
144,879
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
57,264

Versant Ophthalmic Affiliates I, L.P.

10% Owner

Transactions

Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
144,879

Versant Ventures V GP-GP (Canada), Inc.

10% Owner

Transactions

Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
144,879
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
63,387

Versant Ventures V, LLC

10% Owner

Transactions

Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
144,879

Versant Venture Capital VI, L.P.

10% Owner

Transactions

Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
144,879

Versant Ventures V (Canada), L.P.

10% Owner

Transactions

Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
144,879
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
1,903,670

Versant Ventures VI GP, L.P.

10% Owner

Transactions

Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
63,387
Common Shares
(indirect: See Footnote)
144,879

Versant Ventures VI GP-GP, LLC

10% Owner

Transactions

Other
Common Shares
2021-08-05−152,071→ 231,211 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,279→ 2,279 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,279→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-08-05+2,260→ 2,260 total(indirect: See Footnote)
Other
Common Shares
2021-08-05−2,260→ 0 total(indirect: See Footnote)

Holdings

Common Shares
(indirect: See Footnote)
2,594,451
Common Shares
(indirect: See Footnote)
57,264
Common Shares
(indirect: See Footnote)
144,879
Common Shares
(indirect: See Footnote)
1,903,670
Common Shares
(indirect: See Footnote)
63,387

Footnotes (13)

[F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. ("VV I") to its partners pursuant to a Rule 10b5-1 trading plan.
[F10]Shares held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F11]Shares held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F12]Shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F13]Shares held by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F2]Shares held by VV I. Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F3]Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I.
[F4]Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners.
[F6]Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP.
[F7]Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F8]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members.
[F9]Shares held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Repare Therapeutics Inc.

CIK 0001808158

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001589095

Filing Metadata

Form type: 4
Filed: Aug 8, 8:00 PM ET
Accepted: Aug 9, 4:44 PM ET
Size: 37.2 KB

View on SEC.gov